Anergis

Anergis is a clinical stage Swiss biotech developing breakthrough allergy vaccines for ultra-fast and safe desensitisation in only 2 months

  • Stage Product In Development
  • Industry Biotechnology
  • Location Chemin des Croisettes, Epalinges, VD, Switzerland
  • Currency CHF
  • Founded June 2001
  • Employees 10
  • Website anergis.ch

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free